Study of the Choroidal Thickness Variations After Ingestion of RedBull® Energy Drink
NCT ID: NCT02856256
Last Updated: 2017-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-11-12
2017-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
RedBull® is an energizing drink, where one single 25 cl can contains 80 mg of caffeine (the equivalent of a coffee mug) and 1 g of taurine.
This pilot trial aims to study the variations of the choroidal thickness and to describe possible modifications within the pigmentary epithelium, due to the ingestion of caffeine and taurine. The results of this study will act as a reference for an ulterior trial aiming specific choroidal pathologies of young patients, such as the central serous chorioretinitis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness
NCT02321189
Intervention Trial in Early Age-related Macular Degeneration
NCT01694680
Effects of Ginkgo (Gingko Biloba) on Retinal and Choroidal Ocular Tissue
NCT04448535
Carotenoid Supplementation and Retinal Health in Healthy Adults
NCT07314411
Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients
NCT04590196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RedBull® energy drink
RedBull® energy drink
Subjects consume 25 mL of RedBull® energy drink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RedBull® energy drink
Subjects consume 25 mL of RedBull® energy drink
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subject under no medical treatment who can alter choroidal depth (sildenafil, diuretics, steroids, etc)
* Non smoker
* subject who has not ingested any caffeine within the 12 hours prior to the trial's inclusion
* subject well informed of the trial and having signed consent
Exclusion Criteria
* Diabetic subject
* Hypermetropia \> +3 diopters and myopia \< -3 diopters
* History of intra-ocular surgery or laser
* subject with a history of retinal pathologies
* Subject not affiliated to French social security
* Subject under juridical protection
* Pregnant woman
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Ophtalmologique Adolphe de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arej N, Azar G, Salviat F, Alonso AS, Zuber K, Metten MA, Salomon L, Vasseur V, Mauget-Faysse M. Study of choroidal thickness variations after ingestion of a taurine and caffeine-containing energy drink. Clin Nutr ESPEN. 2021 Jun;43:245-249. doi: 10.1016/j.clnesp.2021.04.007. Epub 2021 Apr 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMT_2015_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.